Sally Wenzel
Sally Wenzel üzerinde doğrulanmış e-posta adresine sahip
Alıntı yapanlar
Alıntı yapanlar
Standardisation of spirometry
MR Miller, J Hankinson, V Brusasco, F Burgos, R Casaburi, A Coates, ...
European respiratory journal 26 (2), 319-338, 2005
Global strategy for asthma management and prevention: GINA executive summary
ED Bateman, SS Hurd, PJ Barnes, J Bousquet, JM Drazen, M FitzGerald, ...
European Respiratory Journal 31 (1), 143-178, 2008
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
KF Chung, SE Wenzel, JL Brozek, A Bush, M Castro, PJ Sterk, IM Adcock, ...
European respiratory journal 43 (2), 343-373, 2014
Asthma phenotypes: the evolution from clinical to molecular approaches
SE Wenzel
Nature medicine 18 (5), 716, 2012
Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program
WC Moore, DA Meyers, SE Wenzel, WG Teague, H Li, X Li, ...
American journal of respiratory and critical care medicine 181 (4), 315-323, 2010
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical …
HK Reddel, DR Taylor, ED Bateman, LP Boulet, HA Boushey, WW Busse, ...
American journal of respiratory and critical care medicine 180 (1), 59-99, 2009
Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics
SE Wenzel, LB Schwartz, EL Langmack, JL Halliday, JB Trudeau, ...
American journal of respiratory and critical care medicine 160 (3), 1001-1008, 1999
Asthma: defining of the persistent adult phenotypes
SE Wenzel
The Lancet 368 (9537), 804-813, 2006
Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome
J Lötvall, CA Akdis, LB Bacharier, L Bjermer, TB Casale, A Custovic, ...
Journal of Allergy and Clinical Immunology 127 (2), 355-360, 2011
Dupilumab in persistent asthma with elevated eosinophil levels
S Wenzel, L Ford, D Pearlman, S Spector, L Sher, F Skobieranda, L Wang, ...
New England Journal of Medicine 368 (26), 2455-2466, 2013
Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma
EH Bel, SE Wenzel, PJ Thompson, CM Prazma, ON Keene, SW Yancey, ...
New England journal of medicine 371 (13), 1189-1197, 2014
Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose glucocorticoids
SE Wenzel, SJ Szefler, DYM Leung, SI Sloan, MD Rex, RJ Martin
American journal of respiratory and critical care medicine 156 (3), 737-743, 1997
Characterization of the severe asthma phenotype by the national heart, lung, and blood institute's severe asthma research program
WC Moore, ER Bleecker, D Curran-Everett, SC Erzurum, BT Ameredes, ...
Journal of Allergy and Clinical Immunology 119 (2), 405-413, 2007
Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma
J Bousquet, E Mantzouranis, AA Cruz, N Aït-Khaled, CE Baena-Cagnani, ...
Journal of Allergy and Clinical Immunology 126 (5), 926-938, 2010
A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma
P Flood-Page, C Swenson, I Faiferman, J Matthews, M Williams, ...
American journal of respiratory and critical care medicine 176 (11), 1062-1071, 2007
Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations
DG Torgerson, EJ Ampleford, GY Chiu, WJ Gauderman, CR Gignoux, ...
Nature genetics 43 (9), 887, 2011
Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study
NA Hanania, S Wenzel, K Rosén, HJ Hsieh, S Mosesova, DF Choy, P Lal, ...
American journal of respiratory and critical care medicine 187 (8), 804-811, 2013
Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma
M Castro, J Corren, ID Pavord, J Maspero, S Wenzel, KF Rabe, ...
New England Journal of Medicine 378 (26), 2486-2496, 2018
Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies
S Wenzel, D Wilbraham, R Fuller, EB Getz, M Longphre
The Lancet 370 (9596), 1422-1431, 2007
Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a …
S Wenzel, M Castro, J Corren, J Maspero, L Wang, B Zhang, G Pirozzi, ...
The Lancet 388 (10039), 31-44, 2016
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20